Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

Matthew D. Tucker, Landon C. Brown, Yu-Wei Chen, Chester Kao, Nathan Hirshman, Emily N. Kinsey, Kristin K. Ancell, Kathryn E. Beckermann, Nancy B. Davis, Renee McAlister, Kerry Schaffer, Andrew J. Armstrong, Michael R. Harrison, Daniel J. George, W. Kimryn Rathmell, Brian I. Rini, Tian Zhang

Open source

DOI: 10.1186/s40364-021-00334-4
Published: 2021-11-03
Container: Biomarker Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40364-021-00334-4,
  title = {Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma},
  author = {Matthew D. Tucker and Landon C. Brown and Yu-Wei Chen and Chester Kao and Nathan Hirshman and Emily N. Kinsey and Kristin K. Ancell and Kathryn E. Beckermann and Nancy B. Davis and Renee McAlister and Kerry Schaffer and Andrew J. Armstrong and Michael R. Harrison and Daniel J. George and W. Kimryn Rathmell and Brian I. Rini and Tian Zhang},
  year = {2021},
  journal = {Biomarker Research},
  doi = {10.1186/s40364-021-00334-4},
  url = {https://doi.org/10.1186/s40364-021-00334-4}
}

RIS

TY  - JOUR
TI  - Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
AU  - Matthew D. Tucker
AU  - Landon C. Brown
AU  - Yu-Wei Chen
AU  - Chester Kao
AU  - Nathan Hirshman
AU  - Emily N. Kinsey
AU  - Kristin K. Ancell
AU  - Kathryn E. Beckermann
AU  - Nancy B. Davis
AU  - Renee McAlister
AU  - Kerry Schaffer
AU  - Andrew J. Armstrong
AU  - Michael R. Harrison
AU  - Daniel J. George
AU  - W. Kimryn Rathmell
AU  - Brian I. Rini
AU  - Tian Zhang
PY  - 2021
JO  - Biomarker Research
DO  - 10.1186/s40364-021-00334-4
UR  - https://doi.org/10.1186/s40364-021-00334-4
ER  -

APA

Tucker, M. D., Brown, L. C., Chen, Y., Kao, C., Hirshman, N., Kinsey, E. N., Ancell, K. K., Beckermann, K. E., Davis, N. B., McAlister, R., Schaffer, K., Armstrong, A. J., Harrison, M. R., George, D. J., Rathmell, W. K., Rini, B. I., & Zhang, T. (2021). Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma. Biomarker Research. https://doi.org/10.1186/s40364-021-00334-4

Source records

crossref · retrieved 2026-09-25T13:15:31.139Z